Literature DB >> 1711032

Labeling of integrin alpha v beta 3 with 58Co(III). Evidence of metal ion coordination sphere involvement in ligand binding.

J W Smith1, D A Cheresh.   

Abstract

Integrin-mediated cell adhesion to the extracellular matrix is divalent metal ion-dependent; however, a demonstration of the interaction between native integrins and divalent metal ions is lacking. Here we provide direct evidence that the vitronectin receptor (VNR) is a metalloprotein. The unique electron shell of Co(II), an ion which we show supports ligand recognition by VNR, enables its oxidative conversion to inert Co(III). This property facilitated "affinity labeling" of VNR with 58Co(III) by oxidation of the metal ion in situ (i.e. in position). An average of 3.5 +/- 0.5 mol of cobalt were incorporated per mol of VNR. The ability of VNR to bind metal ions was independently confirmed by examining the interaction between VNR and Mn2+ under native conditions. The apparent high affinity between VNR and Mn2+ allowed us to observe the specific binding between 54Mn2+ and VNR by equilibrium gel filtration studies. Interestingly, the oxidative incorporation of Co(III) into VNR specifically blocked ligand binding, suggesting that the coordination sphere of metal ion bound to VNR is a critical determinant in integrin-ligand recognition. Furthermore, Mn2+ abolished the oxidative affinity labeling of VNR with Co(III) and consequently blocked the inactivation of VNR by in situ incorporation of Co(III). Thus, Mn2+ and Co2+ bind to the same or mutually exclusive sites on VNR. These observations provide the first demonstration that an integrin, specifically VNR, is a metalloprotein and demonstrate a functional link between the coordination sphere of the bound metal ion and ligand recognition by this receptor.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1711032

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  The immune dysregulatory compound mercuric chloride induces integrin-mediated T-lymphocyte adhesion.

Authors:  A Roos; M Neeft; L Engelen; E J Schilder-Tol; U Kunzendorf; J J Weening; J Aten
Journal:  Immunology       Date:  2001-01       Impact factor: 7.397

2.  Regulation of cellular interactions with laminin by integrin cytoplasmic domains: the A and B structural variants of the alpha 6 beta 1 integrin differentially modulate the adhesive strength, morphology, and migration of macrophages.

Authors:  L M Shaw; A M Mercurio
Journal:  Mol Biol Cell       Date:  1994-06       Impact factor: 4.138

3.  Homology modelling of integrin EF-hands. Evidence for widespread use of a conserved cation-binding site.

Authors:  D S Tuckwell; A Brass; M J Humphries
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

4.  Characterization of Endothelial Progenitor Cell Interactions with Human Tropoelastin.

Authors:  Young Yu; Steven G Wise; Praveesuda L Michael; Daniel V Bax; Gloria S C Yuen; Matti A Hiob; Giselle C Yeo; Elysse C Filipe; Louise L Dunn; Kim H Chan; Hamid Hajian; David S Celermajer; Anthony S Weiss; Martin K C Ng
Journal:  PLoS One       Date:  2015-06-26       Impact factor: 3.240

5.  Integrin LFA-1 alpha subunit contains an ICAM-1 binding site in domains V and VI.

Authors:  P Stanley; P A Bates; J Harvey; R I Bennett; N Hogg
Journal:  EMBO J       Date:  1994-04-15       Impact factor: 11.598

6.  CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium.

Authors:  L Piali; P Hammel; C Uherek; F Bachmann; R H Gisler; D Dunon; B A Imhof
Journal:  J Cell Biol       Date:  1995-07       Impact factor: 10.539

7.  Interaction of leukocyte integrins with ligand is necessary but not sufficient for function.

Authors:  I Dransfield; C Cabañas; J Barrett; N Hogg
Journal:  J Cell Biol       Date:  1992-03       Impact factor: 10.539

8.  Mutation of putative divalent cation sites in the alpha 4 subunit of the integrin VLA-4: distinct effects on adhesion to CS1/fibronectin, VCAM-1, and invasin.

Authors:  A Masumoto; M E Hemler
Journal:  J Cell Biol       Date:  1993-10       Impact factor: 10.539

9.  A novel LFA-1 activation epitope maps to the I domain.

Authors:  R C Landis; R I Bennett; N Hogg
Journal:  J Cell Biol       Date:  1993-03       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.